Search research articles
Contact Us
Filters
Showing results (91-100 of 100) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 100 results.
Blood Cancer Journal
|
December 1, 2023
Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index
Jón Þórir Óskarsson, Sæmundur Rögnvaldsson, Sigrun Thorsteinsdottir, et al.
Annals of Internal Medicine
|
April 1, 2024
Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial
Elias Eythorsson, Saemundur Rognvaldsson, Sigrun Thorsteinsdottir, et al.
Blood Cancer Journal
|
December 2, 2021
Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study
Saemundur Rognvaldsson, Elias Eythorsson, Sigrun Thorsteinsdottir, et al.
Annals of Internal Medicine
|
May 20, 2024
Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance : An Analysis From a Population-Based Screening Study
Ingigerdur Sverrisdottir, Sigrun Thorsteinsdottir, Sæmundur Rognvaldsson, et al.
Immunology
|
May 1, 2021
Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva
Sian E Faustini, Sian E Jossi, Marisol Perez-Toledo, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 27, 2020
Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection
Sian E Faustini, Sian E Jossi, Marisol Perez-Toledo, et al.
Blood Cancer Journal
|
April 11, 2026
Impact of SARS-CoV-2 vaccination on monoclonal gammopathy of undetermined significance: results from the population-based iStopMM study
Robert Palmason, Elias Eythorsson, Sæmundur Rögnvaldsson, et al.
The Lancet. Haematology
|
March 28, 2022
Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study
Habib El-Khoury, David J Lee, Jean-Baptiste Alberge, et al.
Blood Cancer Journal
|
March 20, 2023
Correction: Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies
Sæmundur Rögnvaldsson, Thorvardur Jon Love, Sigrun Thorsteinsdottir, et al.
Blood Cancer Journal
|
May 18, 2021
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies
Sæmundur Rögnvaldsson, Thorvardur Jon Love, Sigrun Thorsteinsdottir, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 100) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 100 results.
Blood Cancer Journal
|
December 1, 2023
Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index
Jón Þórir Óskarsson, Sæmundur Rögnvaldsson, Sigrun Thorsteinsdottir, et al.
Annals of Internal Medicine
|
April 1, 2024
Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial
Elias Eythorsson, Saemundur Rognvaldsson, Sigrun Thorsteinsdottir, et al.
Blood Cancer Journal
|
December 2, 2021
Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study
Saemundur Rognvaldsson, Elias Eythorsson, Sigrun Thorsteinsdottir, et al.
Annals of Internal Medicine
|
May 20, 2024
Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance : An Analysis From a Population-Based Screening Study
Ingigerdur Sverrisdottir, Sigrun Thorsteinsdottir, Sæmundur Rognvaldsson, et al.
Immunology
|
May 1, 2021
Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva
Sian E Faustini, Sian E Jossi, Marisol Perez-Toledo, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 27, 2020
Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection
Sian E Faustini, Sian E Jossi, Marisol Perez-Toledo, et al.
Blood Cancer Journal
|
April 11, 2026
Impact of SARS-CoV-2 vaccination on monoclonal gammopathy of undetermined significance: results from the population-based iStopMM study
Robert Palmason, Elias Eythorsson, Sæmundur Rögnvaldsson, et al.
The Lancet. Haematology
|
March 28, 2022
Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study
Habib El-Khoury, David J Lee, Jean-Baptiste Alberge, et al.
Blood Cancer Journal
|
March 20, 2023
Correction: Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies
Sæmundur Rögnvaldsson, Thorvardur Jon Love, Sigrun Thorsteinsdottir, et al.
Blood Cancer Journal
|
May 18, 2021
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies
Sæmundur Rögnvaldsson, Thorvardur Jon Love, Sigrun Thorsteinsdottir, et al.
Page
of 10